Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Quantitative Imaging in Medicine and Surgery|September 15, 2023
Sequential liquid-based cytology based on exfoliative cells of 18-gauge core needle groove to improve renal mass core needle biopsy yield: a real-world observational studyJie Han, Feiya Yang, Bo Wang, et al.
Translational Andrology and Urology|January 28, 2016
Laparoscopic simple prostatectomy with prostatic urethra preservation for benign prostatic hyperplasiaNianzeng Xing, Yinglu Guo, Feiya Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 17, 2023
Polyphotosensitizer-Based Nanoparticles with Michael Addition Acceptors Inhibiting GST Activity and Cisplatin Deactivation for Enhanced Chemotherapy and Photodynamic ImmunotherapyQinxin Zhao, Ganghao Liang, Boda Guo, et al.
Oncology Letters|May 8, 2018
Expression of CD74 in bladder cancer and its suppression in association with cancer proliferation, invasion and angiogenesis in HT-1376 cellsJun-Wei Gai, Wasilijiang Wahafu, Liming Song, et al.
Scientific Reports|May 10, 2025
The impact of radiotherapy on the prognosis of metastatic clear cell renal cell carcinoma after surgeryXuwen Li, Zhongyu Tan, Yihao Zhu, et al.
Discover Oncology|September 3, 2025
Identification and verification of exosome-related gene signature to predict the cancer status and prognosis of prostate cancerHaoxi Wang, Xuwen Li, Liyuan Wu, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 21, 2025
PSMA-Targeted Nanoparticles with PI3K/mTOR Dual Inhibitor Downregulate P-Glycoprotein and Inactivate Myeloid-Derived Suppressor Cells for Enhanced Chemotherapy and Immunotherapy in Prostate CancerLu Yin, Feiya Yang, Wenkuan Wang, et al.
Nature Communications|February 14, 2019
Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancerSong Wu, Tong Ou, Nianzeng Xing, et al.
BMC Urology|November 18, 2019
The long-term efficacy of one-shot neoadjuvant intra-arterial chemotherapy combined with radical cystectomy versus radical cystectomy alone for bladder cancer: a propensity-score matching studyWasilijiang Wahafu, Sai Liu, Wenbin Xu, et al.
Cancer Communications (London, England)|June 16, 2022
The establishment of polypeptide PSMA-targeted chimeric antigen receptor-engineered natural killer cells for castration-resistant prostate cancer and the induction of ferroptosis-related cell deathLiyuan Wu, Fei Liu, Le Yin, et al.
Pageof 7